European Journal of Chemistry 2016, 7(1), 19-29. doi:10.5155/eurjchem.7.1.19-29.1346

Article Metrics

Abstract of this article was viewed 565 times | PDF Article downloaded 218 times

How to cite


Amin, K.; El-Badry, O.; Rahman, D.; Ammar, U.; Abdalla, M. Eur. J. Chem. 2016, 7(1), 19-29. doi:10.5155/eurjchem.7.1.19-29.1346
Amin, K.; El-Badry, O.; Rahman, D.; Ammar, U.; Abdalla, M. Design, synthesis, anticancer evaluation and molecular docking of new V600EBRAF inhibitors derived from pyridopyrazinone. Eur. J. Chem. 2016, 7(1), 19-29. doi:10.5155/eurjchem.7.1.19-29.1346
Amin, K., El-Badry, O., Rahman, D., Ammar, U., & Abdalla, M. (2016). Design, synthesis, anticancer evaluation and molecular docking of new V600EBRAF inhibitors derived from pyridopyrazinone. European Journal of Chemistry, 7(1), 19-29. doi:10.5155/eurjchem.7.1.19-29.1346
Amin, Kamelia, Ossama Metwally El-Badry, Doaa Ezzat Abdel Rahman, Usama Magdi Ammar, & Mohamed Mostafa Abdalla. "Design, synthesis, anticancer evaluation and molecular docking of new V600EBRAF inhibitors derived from pyridopyrazinone." European Journal of Chemistry [Online], 7.1 (2016): 19-29. Web. 17 Sep. 2019
Amin, Kamelia, El-Badry, Ossama, Rahman, Doaa, Ammar, Usama, AND Abdalla, Mohamed. "Design, synthesis, anticancer evaluation and molecular docking of new V600EBRAF inhibitors derived from pyridopyrazinone" European Journal of Chemistry [Online], Volume 7 Number 1 (31 March 2016)

Refbacks

  • There are currently no refbacks.




Copyright (c)




© Copyright 2019  Atlanta Publishing House LLC All Right Reserved.

The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.

Copyright 2019 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 4614 Lavista road, Tucker, GA, 30084, USA. Registered in USA.